September 20, 2010

A Food and Drug Administration advisory committee has recommended approval of a drug for patients...

September 19, 2010

Biotech company Genentech has amended its application to the Food and Drug Administration seeking an...

September 16, 2010

Boehringer Ingelheim has started a late-stage clinical trial of a drug for treating breast cancer,...

September 16, 2010

Emergent BioSolutions has landed a $51 million contract from the Department of Health and Human...

September 16, 2010

The Food and Drug Administration has accepted for review a regulatory approval application for a...

September 16, 2010

An advisory committee of the Food and Drug Administration has given a thumbs-down to a...

September 13, 2010

Biotech companies Seattle Genetics and Genmab will collaborate to develop antibody treatments for cancer, the...

September 12, 2010

The Food and Drug Administration has accepted a regulatory approval application for a flu vaccine...

September 12, 2010

The Food and Drug Administration did not completely withdraw from the market a drug used...

September 12, 2010

An investigational treatment for HIV by Gilead Sciences that combines four drugs in one tablet...

September 9, 2010

Close to 400 drugs and vaccines are in development for fighting infectious diseases, according to...

September 9, 2010

Diplomat Specialty Pharmacy isn’t the only one to earn a spot on Inc. magazine’s list...

September 8, 2010

Inc. magazine has ranked Diplomat Specialty Pharmacy as one of the fastest-growing private companies in...

September 8, 2010

NEW YORK British drug maker GlaxoSmithKline and biotech company Genmab have started a late-stage trial...

September 8, 2010

British drug maker Shire is working with Cambridge, Mass.-based Acceleron Pharma to develop treatments for...

September 6, 2010

Biotech drugs for treating Alzheimer’s disease will more than triple the size of the market...

September 2, 2010

Pfizer is pulling out of a development deal for a potential brain cancer drug, saying...

August 31, 2010

A specialty biopharmaceutical company focused on the development and commercialization of innovative treatments for diabetes...

August 31, 2010

The Food and Drug Administration has granted priority review for a diabetic macular edema treatment....

August 31, 2010

Pfizer announced Wednesday that it will acquire a privately held drug discovery and clinical development...

August 30, 2010

The U.S. drug market will present opportunities as well as uncertainties over the next decade,...

August 29, 2010

BioMarin Pharmaceutical on Monday announced its investigational treatment for a lysosomal storage disorder has received...

August 29, 2010

Meda on Monday announced an agreement to acquire the specialty pharmaceutical company Alaven in a...

August 29, 2010

The Apothecary Shops, a Phoenix-based chain of specialty pharmacies with 16 locations in six states,...